February 19th, 2025 Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference SAN FRANCISCO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today ...

A novel pipeline of breast cancer candidates that work to antagonize the estrogen receptor (ER) and block the ER-mediated cancer cell growth and proliferation signal.